Makscientific

151 S Bedford St Ste 3
Burlington, MA 01803

MAKScientific is a Boston-based pharmaceutical company that is dedicated to developing drugs targeting the endocannabinoid system to treat various medical disorders. With a focus on selective targeting of components such as cannabinoid receptors and enzymes, they have a growing portfolio of small molecule modulators that have shown promise in animal models of human disease.

One of their advanced drug candidates, AM6545, is a peripherally restricted CB1 receptor antagonist that offers a potential new approach to managing chronic liver disease and metabolic disorders. Seeking a partner for further development and commercialization, MAKScientific has already advanced this drug candidate to the late pre-clinical stage with no adverse pre-clinical data to date.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.